Calamos Advisors LLC Raises Stake in Amedisys, Inc. (NASDAQ:AMED)

Calamos Advisors LLC boosted its holdings in Amedisys, Inc. (NASDAQ:AMED) by 22.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 487,444 shares of the health services provider’s stock after buying an additional 90,097 shares during the period. Calamos Advisors LLC’s holdings in Amedisys were worth $44,255,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in AMED. Pacer Advisors Inc. lifted its stake in Amedisys by 11,621.9% during the fourth quarter. Pacer Advisors Inc. now owns 558,197 shares of the health services provider’s stock worth $50,679,000 after purchasing an additional 553,435 shares during the last quarter. Polar Asset Management Partners Inc. bought a new position in Amedisys during the third quarter valued at approximately $28,953,000. Verition Fund Management LLC raised its stake in shares of Amedisys by 608.1% during the third quarter. Verition Fund Management LLC now owns 114,774 shares of the health services provider’s stock worth $11,077,000 after acquiring an additional 98,565 shares in the last quarter. Westchester Capital Management LLC lifted its holdings in shares of Amedisys by 9.5% in the 3rd quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider’s stock worth $107,976,000 after acquiring an additional 97,476 shares during the last quarter. Finally, Oddo BHF Asset Management Sas purchased a new stake in shares of Amedisys in the 3rd quarter valued at $7,238,000. Institutional investors own 94.36% of the company’s stock.

Amedisys Stock Down 0.4 %

Shares of Amedisys stock opened at $92.15 on Tuesday. The stock has a market capitalization of $3.02 billion, a price-to-earnings ratio of 36.57, a P/E/G ratio of 1.82 and a beta of 0.73. The company’s 50 day moving average price is $89.43 and its 200-day moving average price is $93.92. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys, Inc. has a 52-week low of $82.15 and a 52-week high of $98.95.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The business had revenue of $587.67 million during the quarter, compared to analysts’ expectations of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Amedisys’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the firm posted $0.98 EPS. Equities research analysts forecast that Amedisys, Inc. will post 4.4 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.